{"id":{"repo_id":"msu","oai_identifier":"oai:d.lib.msu.edu:etd_52158"},"canonical_url":"https://search.ndltd.org/etd/msu/oai:d.lib.msu.edu:etd_52158","repository":{"repo_id":"msu","name":"Michigan State University","base_url":"https://d.lib.msu.edu/oai"},"display":{"title":"INVESTIGATION INTO MODULATORS OF NFκB AND MRTF/SRF-REGULATED GENE TRANSCRIPTION","abstract":"Thesis (Ph.D.)--Michigan State University. Biochemistry and Molecular Biology - Doctor of Philosophy, 2024","abstract_html":"Thesis (Ph.D.)--Michigan State University. Biochemistry and Molecular Biology - Doctor of Philosophy, 2024","abstract_has_math":false,"creators":["Meschkewitz, Melissa"],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":["Neubig, Richard R","Lisabeth, Erika M","Martinez Hackert, Erik","Henry, Ronald W","Dickson, Alexander"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2024,"date_issued":"2024","date_published":"2024","updated_at":"2026-11-18T18:58:52Z","subjects":["Molecular biology","Pharmacology"],"languages":["eng"],"rights":["In Copyright"],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["etd:52158","local:Meschkewitz_grad.msu_0128D_21051"],"render_values":[{"text":"etd:52158","href":null,"code":true},{"text":"local:Meschkewitz_grad.msu_0128D_21051","href":null,"code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://doi.org/doi:10.25335/1x0c-2g17","outbound_label":"DOI","outbound_source":"dc:identifier","record_url":"https://doi.org/doi:10.25335/1x0c-2g17","record_label":"Repository record","record_kind":"doi","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://d.lib.msu.edu/oai?verb=GetRecord&metadataPrefix=oai_dc&identifier=oai%3Ad.lib.msu.edu%3Aetd_52158","prefix":"oai_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Neubig, Richard R","Lisabeth, Erika M","Martinez Hackert, Erik","Henry, Ronald W","Dickson, Alexander"]},{"key":"dc:creator","label":"Author","values":["Meschkewitz, Melissa"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2024"]},{"key":"dc:relation","label":"Dc Relation","values":["Electronic Theses & Dissertations"]},{"key":"dc:type","label":"Dc Type","values":["text","Electronic dissertations"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Molecular biology","Pharmacology"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["eng"]},{"key":"dc:rights","label":"Dc Rights","values":["In Copyright"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["etd:52158","local:Meschkewitz_grad.msu_0128D_21051","https://doi.org/doi:10.25335/1x0c-2g17"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Thesis (Ph.D.)--Michigan State University. Biochemistry and Molecular Biology - Doctor of Philosophy, 2024","NFκB signaling and MRTF/SRF signaling are not often related to each other. However, one protein, pirin, has been identified in both regulatory pathways with the potential to modulate gene transcription. Pirin is a non-heme iron-binding protein with a variety of proposed functions. Our lab discovered pirin as the main target of a series of small molecule compounds, CCG-1423 and related compounds. These compounds were originally discovered in a screen to find novel inhibitors for the MRTF/SRF signaling pathway, but pirin was identified as the main target. Evidence of pirin involvement in MRTF/SRF signaling is limited. However, there has been research linking pirin to NFκB signaling as a transcriptional co-activator. Specifically, it was found that Fe(III)-pirin binds to the p65 subunit of NFκB. In this dissertation, in Chapter 2, I first focused on confirming that pirin interacts with and modulates p65 signaling through binding to the p65/DNA complex in cells. However, after extensive investigation of pirin’s potential interaction with p65, I was not able to detect complex formation. Furthermore, knockdown of pirin did not alter p65 response gene expression. Further supporting the lack of binding to the p65/DNA complex, pirin immunofluorescence in NIH 3T3 fibroblasts showed primarily cytoplasmic localization and colocalization with the endoplasmic reticulum. Another proposed function of pirin is as a qeurcetinase. This research confirms pirin’s quercetinase activity and shows inhibition of enzymatic activity through CCG compounds. In Chapter 3, I focus on the development of a direct MRTF-A/SRF inhibitor peptide. The CCG compounds bind to pirin and do not show engagement with proteins in the MRTF/SRF signaling pathway. However, a 21-amino acid peptide from the basic region 1 of MRTF-A is sufficient for disrupting MRTF-A binding to SRF in vitro. Here, I show that we can use this peptide as a starting point to develop a direct inhibitor binding to SRF. By using Amplified Luminescence Proximity Homogenous Assay (ALPHA) I was able to detect that a single amino acid change of Tyr to Phe can decrease peptide IC50 almost 3-fold. Additionally, I found the shortest peptide sequence without loss in inhibitory capacity to be a 14-mer peptide. Unfortunately, in a cellular reporter assay, peptides did not show inhibition of MRTF/SRF signaling. Therefore, further improvement of peptides will be necessary to develop them as functional MRTF/SRF inhibitors in cells.","Description based on online resource. Title from PDF t.p. (Michigan State University Fedora Repository, viewed ).","Includes bibliographical references."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf","1 online resource (137 p.) : ill."]},{"key":"dc:title","label":"Title","values":["INVESTIGATION INTO MODULATORS OF NFκB AND MRTF/SRF-REGULATED GENE TRANSCRIPTION"]}]}],"canonical_facts":{"dc:contributor":["Neubig, Richard R","Lisabeth, Erika M","Martinez Hackert, Erik","Henry, Ronald W","Dickson, Alexander"],"dc:creator":["Meschkewitz, Melissa"],"dc:date":["2024"],"dc:description":["Thesis (Ph.D.)--Michigan State University. Biochemistry and Molecular Biology - Doctor of Philosophy, 2024","NFκB signaling and MRTF/SRF signaling are not often related to each other. However, one protein, pirin, has been identified in both regulatory pathways with the potential to modulate gene transcription. Pirin is a non-heme iron-binding protein with a variety of proposed functions. Our lab discovered pirin as the main target of a series of small molecule compounds, CCG-1423 and related compounds. These compounds were originally discovered in a screen to find novel inhibitors for the MRTF/SRF signaling pathway, but pirin was identified as the main target. Evidence of pirin involvement in MRTF/SRF signaling is limited. However, there has been research linking pirin to NFκB signaling as a transcriptional co-activator. Specifically, it was found that Fe(III)-pirin binds to the p65 subunit of NFκB. In this dissertation, in Chapter 2, I first focused on confirming that pirin interacts with and modulates p65 signaling through binding to the p65/DNA complex in cells. However, after extensive investigation of pirin’s potential interaction with p65, I was not able to detect complex formation. Furthermore, knockdown of pirin did not alter p65 response gene expression. Further supporting the lack of binding to the p65/DNA complex, pirin immunofluorescence in NIH 3T3 fibroblasts showed primarily cytoplasmic localization and colocalization with the endoplasmic reticulum. Another proposed function of pirin is as a qeurcetinase. This research confirms pirin’s quercetinase activity and shows inhibition of enzymatic activity through CCG compounds. In Chapter 3, I focus on the development of a direct MRTF-A/SRF inhibitor peptide. The CCG compounds bind to pirin and do not show engagement with proteins in the MRTF/SRF signaling pathway. However, a 21-amino acid peptide from the basic region 1 of MRTF-A is sufficient for disrupting MRTF-A binding to SRF in vitro. Here, I show that we can use this peptide as a starting point to develop a direct inhibitor binding to SRF. By using Amplified Luminescence Proximity Homogenous Assay (ALPHA) I was able to detect that a single amino acid change of Tyr to Phe can decrease peptide IC50 almost 3-fold. Additionally, I found the shortest peptide sequence without loss in inhibitory capacity to be a 14-mer peptide. Unfortunately, in a cellular reporter assay, peptides did not show inhibition of MRTF/SRF signaling. Therefore, further improvement of peptides will be necessary to develop them as functional MRTF/SRF inhibitors in cells.","Description based on online resource. Title from PDF t.p. (Michigan State University Fedora Repository, viewed ).","Includes bibliographical references."],"dc:format":["application/pdf","1 online resource (137 p.) : ill."],"dc:identifier":["etd:52158","local:Meschkewitz_grad.msu_0128D_21051","https://doi.org/doi:10.25335/1x0c-2g17"],"dc:language":["eng"],"dc:relation":["Electronic Theses & Dissertations"],"dc:rights":["In Copyright"],"dc:subject":["Molecular biology","Pharmacology"],"dc:title":["INVESTIGATION INTO MODULATORS OF NFκB AND MRTF/SRF-REGULATED GENE TRANSCRIPTION"],"dc:type":["text","Electronic dissertations"]},"updated_at":"2026-11-18T18:58:52Z"}